Matches 1 - 45 out of 45


Match Document Document Title
US20160235792 PROBIOTIC AND PREBIOTIC COMPOSITIONS, AND METHODS OF USE THEREOF FOR TREATMENT AND PREVENTION OF GRAFT VERSUS HOST DISEASE  
Probiotic compositions containing non-pathogenic microbial entities, e.g., bacterial or fungal entities, are described herein. The probiotic compositions may optionally contain or be used in...
US20160193329 Deletion Mutants of Flagellin and Methods of Use  
Compositions that include at least a portion of a flagellin and an antigen can be employed in methods that stimulate an immune response in a subject, in particular, a protective immune response in...
US20130039949 IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS  
Provided herein are compounds, compositions and methods for balancing a T-helper cell profile and in particular Th1, Th2, Th17 and Treg cell profiles, and related methods and compositions for...
US20160030464 IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS  
Provided herein are compounds, compositions and methods for balancing a T-helper cell profile and in particular Th1, Th2, Th17 and Treg cell profiles, and related methods and compositions for...
US20140335131 PROBIOTIC PREVENTION AND TREATMENT OF COLON CANCER  
Methods are provided herein for preventing, delaying the onset of or reducing the progression of colorectal tumorigenesis in a subject identified as at risk of colorectal tumorigenesis, comprising...
US20150150945 Modifying Macrophage Phenotype for Treatment of Disease  
The present invention provides compositions and methods for modulating one or more phenotypes of a macrophage-related cell, e.g., a macrophage. The invention further provides methods of treating...
US20120064151 ENHANCED IMMUNE RESPONSE IN AVIAN SPECIES  
The present invention relates to a method of immune activation which is effective for eliciting a non-antigen-specific immune response in a member of the avian species. The method is particularly...
US20140335049 QUIL A FRACTION WITH LOW TOXICITY AND USE THEREOF  
Fraction A of Quil A can be used together with at least one other adjuvant for the preparation of an adjuvant composition, where the included adjuvant components act synergistically to enhance...
US20130295167 ENHANCED IMMUNE RESPONSE IN BOVINE SPECIES  
The present invention relates to a method of immune activation which is effective for eliciting a non-antigen-specific immune response in a member of the bovine species. The method is particularly...
US20080213319 CHEMOREPULSION OF CELLS  
The present invention provides compositions and methods of controlling the direction and/or movement of migratory cells. Specifically, the invention is directed to the identification of novel...
US20110002980 VACCINES USING NUCLEIC ACID-LIPID COMPLEXES  
This invention relates to a vaccine and a method for immune activation which is effective for eliciting both a systemic, non-antigen specific immune response and a strong antigen-specific immune...
US20130236497 TREATING NEOPLASMS WITH NEUROTOXIN  
The present invention provides a method of treating a cancer using a neurotoxin, preferably Botulinum toxin (“BTX”). The application of a neurotoxin around a cancer acts to decrease the...
US20120128727 BACTERIAL EXPRESSION OF AN ARTIFICIAL GENE FOR THE PRODUCTION OF CRM197 AND ITS DERIVATIVES  
The present invention relates to polynucleotide sequences comprising the SEQ ID N° 1 encoding CRM197 and optimised for its expression in E. coli. The invention consequently concerns a method for...
US20120121685 BREAKFAST CEREALS CONTAINING PROBIOTIC MICRO ORGANISMS  
The present invention relates to the field of nutrition. In particular, the present invention relates to a breakfast cereal composition comprising probiotic micro-organisms. These probiotic...
US20130309273 Thermostable Vaccine Compositions and Methods of Preparing Same  
The disclosure provides compositions relating to thermostable vaccines and methods of preparing same. Specifically, the disclosure provides for methods of preparing thermostable vaccines based on...
US20080124350 Nanoparticle-based vaccine delivery system containing adjuvant  
A vaccine delivery system comprising adjuvant and nanoparticles comprising an immunogenic agent is provided. A method of immunizing an animal comprising administering a nanoparticle-based vaccine...
US20120135036 BACTERIAL COMPOSITION AND ITS USE  
The subject of the present invention is a bacterial composition having immunomodulation properties comprising at least one strain selected from the group consisting of Lactobacillus acidophilus...
US20110250237 IMMUNOGENIC AMPHIPATHIC PEPTIDE COMPOSITIONS  
The present application pertains to a composition, comprising (a) amphipathic peptides; (b) lipids and (c) at least one immunogenic species. Respective compositions are suitable for immunogenic...
US20130302380 AGENT FOR INDUCING INTERFERON PRODUCTION CONTAINING LACTIC ACID BACTERIA  
This invention provides an IFN inducer comprising, as an active ingredient, lactic acid bacteria and capable of inducing IFN production, an immunopotentiating agent or prophylactic agent against...
US20070280970 Methods of Treating Wounds With Gonyautoxins  
Pharmaceutical compositions comprising tricyclic 3,4-propinoperhydropurines and uses thereof for blocking neuronal transmission which are useful in treating anal fissure and other wounds and...
US20110171259 Novel Compositions and Adjuvants  
The present invention is directed toward adjuvants that effect an innate and/or a specific immune response. The adjuvants contain at least one lipoprotein, such as Lip, Lip fragments or Lip...
US20130195917 IMMUNOADJUVANT  
The invention thus relates to a method for boosting the efficiency of a vaccine by co-administering a probiotic bacterium such as L. casei 431 or BB-12 with an influenza vaccine. The invention...
US20140112979 METHODS FOR PRODUCING LIPOSOMES  
The invention discloses a method for the formation of liposomes by using high shear mixing of aqueous solution of lipid powder; the lipid powder can be produced by any known technique. Components...
US20100322977 BIOMATERIALS, COMPOSITIONS, AND METHODS  
Embodiments exploit the ability of the organism Bacillus thuringiensis to produce regularly shaped micrometer-sized crystals of Cry insect protoxins. In various embodiments, these crystals are...
US20110086023 COMBINATION ANTIHISTAMINE MEDICATION  
The invention provides a topical pharmaceutical composition for application to the nasal or ocular mucosa which comprises (1) a pharmaceutical excipient suitable for topical administration, (2) a...
US20100330128 Method of improving immune function in mammals using lactobacillus strains with certain lipids  
A method of improving immune-function in mammals using selected 3-HPA producing lactic acid bacteria with a medium chain triglyceride (MCT) oil.
US20100112013 Adjuvant comprising oligonucleotide and non-toxic lipopolysaccharide  
Disclosed is an adjuvant composition of the present invention including the oligodeoxynucleotides and the LPS-derived non-toxic polysaccharides as the major components.
US20120231086 PROTEIN MATRIX VACCINES OF IMPROVED IMMUNOGENICITY  
The present invention relates to immunogenic compositions containing an antigen of interest entrapped with a crosslinked carrier protein matrix, methods of making such vaccines, and methods of...
US20080248068 Use of Flagellin as an Adjuvant for Vaccine  
The present invention is directed to flagellin and its use as an adjuvant for vaccination. The invention can be used in vaccine formulations to improve immunity against any other antigen...
US20160022727 IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS  
Provided herein are compounds, compositions and methods for balancing a T-helper cell profile and in particular Th1, Th2, Th17 and Treg cell profiles, and related methods and compositions for...
US20150093431 COMPOSITIONS  
The present invention relates to a composition comprising at least one mimotope of an epitope of alpha-synuclein for use in a method for preventing and/or treating synucleinopathies, wherein said...
US20120276149 METHODS FOR MODULATING BACTERIAL INFECTION  
The present invention relates to methods for treating or reducing the risk of or preventing diseases caused by or associated with pathogenic bacteria. More particularly, the present invention...
US20110002965 IMMUNOMODULATING COMPOUNDS AND RELATED COMPOSITIONS AND METHODS  
Provided herein are compounds, compositions and methods for balancing a T-helper cell profile and in particular Th1, Th2, Th17 and Treg cell profiles, and related methods and compositions for...
US20160200762 Bioactive polypeptide DELQ and preparation method as well as application thereof  
A milk-derived bioactive polypeptide has in vitro antioxidant activity and an immunity-enhancing function, and an amino acid sequence thereof is DELQ. According to in vitro antioxidant and in...
US20150098959 Mucosal Immunity-Stimulating Agent, and Oral Pharmaceutical Composition for Treating HPV Infection  
A mucosal immunity-stimulating agent contains a Kampo preparation having a revitalizing activity and a mucosal adjuvant. An oral pharmaceutical composition for treating HPV infection contains at...
US20150093432 COMPOSITION  
The present invention relates to a composition comprising at least one mimotope of an epitope of alpha-synuclein for use in a method for preventing and/or treating β-amyloidoses including...
US20140348878 STRAIN OF EXOPOLYSACCHARIDE-SECRETING LACTOBACILLUS BREVIS AND APPLICATION THEREOF  
A strain of exopolysaccharide-secreting Lactobacillus brevis, BDLB0001, and an application thereof. The Lactobacillus brevis is deposited at the China General Microbiological Culture Collection...
US20130064859 COMBINATORIAL VITAMIN D AND PROBIOTIC THERAPY FOR INFLAMMATORY BOWEL DISEASE  
A method of increasing the percentage of mouse and human Tregs is provided comprising providing B.fragilis or PSA and vitamin D or vitamin D metabolite to said mouse or human. Also, a method for...
US20090081156 Bioactive molecular matrix and methods of use in the treatment of disease  
The present invention provides methods and compositions for stimulating an immune response or modulating cell signal transduction in a host by administering to said host a composition comprising...
US20100310511 DETERMINING DISEASE OR IMMUNE SYSTEM FEATURES BASED ON ANALYSIS OF IMMUNE SYSTEM CHARACTERISTICS  
Methods for analyzing one or more elements, markers, ligands or other characteristics of the immune system of a body (e.g., of a human or other animal), and based on the analysis, determine a...
US20120045478 METHOD AND COMPOSITIONS  
A method of preparing a compound of formula (III): wherein x is from 1 to 6, y is from 1 to 12, z is from 0 to 10, each M and each M′ is independently a mycolic acid residue including a β-hydroxy...
US20110305728 DRUG FOR TREATING INFECTIONS  
The invention relates to the use of glycoproteins extracted from the Klebsiella Pneumoniae bacterium for the production of a drug for the remedial treatment of acute or chronic infections. Said...
US20150224188 USE OF MEMBRANE VESICLE-BASED VACCINE AGAINST M. TUBERCULOSIS  
Provided are compositions comprising a plurality of isolated mycobacterium membrane vesicles, and methods of use thereof, and methods of improving the efficacy of immunizations. Throughout this...
US20150147356 ANTIPYRETICS TO ENHANCE TOLERABILITY OF VESICLE-BASED VACCINES  
A method for immunising a human subject, wherein the subject receives (i) an immunogenic composition comprising bacterial vesicles and (ii) an antipyretic, and wherein the immunogenic composition...
US20120148628 Compositions and methods for treatment of cancer  
The present invention contemplates therapeutic constructs comprising superantigen homologues devoid of neutralizing antibodies in human sera conjugated recombinantly to costimulatory and tumor...

Matches 1 - 45 out of 45